Global Gold-199 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Gold-199 market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
In 2025, global Gold-199 production was approximately 78 grams, with an average global market price of around $82,000 per gram. That year, total global production capacity for Gold-199 reached approximately 140 grams. The average gross profit margin for the industry stood at approximately 63%. Gold-199 is an artificial radioactive isotope of gold (Au) with an atomic number of 79 and a mass number of 199. While gold in nature exists primarily as the stable isotope gold-197 (^197Au), ^199Au must be produced through artificial nuclear reactions. With a half-life of approximately 3.14 days, ^199Au decays primarily via beta-minus (β⁻) emission into stable mercury-199 (^199Hg), releasing high-energy beta particles accompanied by gamma radiation. Due to the potent localized radiation-induced cytotoxicity of its beta emissions, ^199Au has been investigated for use in radiotherapy, particularly for localized tumor treatment, radiocolloid therapy, and targeted radionuclide therapy. Furthermore, as it retains the characteristic chemical properties of gold, ^199Au can be utilized for biological labeling in forms such as gold nanoparticles, colloidal gold, and gold complexes; consequently, it has recently garnered renewed interest in the fields of nanomedicine, drug delivery, and radiotracer research. Currently, ^199Au is primarily employed in nuclear medicine research, radiopharmaceutical development, experimental tumor therapy, and studies involving gold-based nanomaterials, representing a classic example of a high-value, small-scale research-grade radioisotope.
The upstream segment of the gold-199 value chain encompasses the supply of high-purity gold target materials, nuclear production facilities, and radioisotope preparation capabilities. Since natural gold consists almost entirely of the stable isotope ^197Au, ^199Au is typically produced by subjecting high-purity ^197Au targets to nuclear reactions. Common production methods include neutron activation in research reactors—where ^199Au is generated via the decay of intermediate nuclides such as ^198Au—or the bombardment of gold targets with particles using an accelerator. This upstream stage requires capabilities in high-purity gold target fabrication, nuclear irradiation, radiochemical processing, and radioactive waste management. Given the short half-life of ^199Au, the window for post-production storage and transport is limited; thus, supply generally relies on regional production centers equipped with the necessary nuclear facilities. Currently, the global supply of Gold-199 (¹⁹⁹Au) is primarily concentrated among national laboratories, nuclear research institutes, and specialized nuclear technology enterprises that possess research reactors, cyclotrons, and radioisotope production capabilities. The midstream segment of the ¹⁹⁹Au value chain encompasses nuclide separation, radiochemical purification, activity measurement, formulation development, and standardized packaging. As nuclear reactions can generate other gold isotopes or impurity nuclides, radiochemical separation methods—such as ion exchange, solvent extraction, and precipitation—are required to obtain ¹⁹⁹Au products with the high radiochemical purity necessary for scientific and medical research. Depending on the intended application, ¹⁹⁹Au can be formulated as gold chloride solutions, colloidal gold particles, gold nanoparticle conjugates, or other gold complexes. Notably, colloidal ¹⁹⁹Au and gold nanoparticle-based ¹⁹⁹Au are utilized in research regarding radioactive tracing and targeted therapy due to their favorable biocompatibility and capacity for local accumulation. Midstream enterprises and institutions face high technical barriers, as operations require expertise in nuclear chemical separation, capabilities for radioactive quality control, and production environments that meet regulatory standards. Looking ahead, the development of high-purity, highly stable ¹⁹⁹Au formulations will become a key focus within the value chain, driven by advancements in nanomedicine and precision radiotherapy. Downstream applications of ¹⁹⁹Au are primarily centered on nuclear medicine research, local radiotherapy, radiopharmaceutical development, and nanomedicine. In the field of nuclear medicine, the beta-emitting properties of ¹⁹⁹Au enable research into local radiotherapy techniques, such as intratumoral injection and radioactive colloid therapy. Furthermore, given the excellent surface modification properties of gold, ¹⁹⁹Au-labeled nanoparticles are used to study drug delivery, cell tracking, and biodistribution. Recent advancements in gold nanomaterials, biomedical engineering, and precision therapy have sparked interest in the application of ¹⁹⁹Au for experimental cancer treatment, targeted drug delivery, and multifunctional nanotheranostic platforms. While ¹⁹⁹Au is unlikely to replace the mainstream radionuclides currently used in clinical radiotherapy, it holds significant value for future applications in scientific innovation, local therapeutic techniques, and nanoradiomedicine.
The development of Gold-199 (^199Au) is primarily driven by continuous advancements in precision radiotherapy and nuclear medicine research. With a half-life of approximately 3.14 days, ^199Au emits β⁻ particles and deposits radiation energy locally, making it suitable for treating localized lesions and for use in radiotracer studies. The evolution of precision cancer therapy concepts has prompted researchers to explore the use of β-emitting radionuclides for the targeted destruction of tumor cells, thereby accelerating the development of various therapeutic radioisotopes, including ^199Au. Furthermore, ^199Au offers excellent chemical modifiability; it can be conjugated with colloidal gold, gold nanoparticles, and targeting ligands to enhance accumulation in target tissues, providing a technical foundation for localized radiotherapy, tumor microenvironment studies, and drug delivery research.
In recent years, advancements in nanomedicine and radiopharmaceutical technology have opened up new application opportunities for Gold-199. Given the excellent biocompatibility, surface functionalization capabilities, and drug-loading capacities of gold nanomaterials, ^199Au-labeled nanoparticles are being utilized in drug delivery research, cell tracking, biodistribution analysis, and the development of targeted therapy platforms. Concurrently, the rise of the "theranostics" concept—integrating diagnosis and therapy—has made the conjugation of radionuclides with antibodies, peptides, and small-molecule drugs a key area of ​​innovation in nuclear medicine, encouraging research institutions to explore diverse application strategies involving ^199Au. As nanoradiomedicine, biomaterials engineering, and precision oncology technologies mature, the value of Gold-199 in scientific research and experimental therapy is expected to increase further.
A stable supply of high-purity radionuclides forms the essential foundation for the Gold-199 industry. Currently, ^199Au is primarily produced via nuclear reactions using high-purity Gold-197 (^197Au) targets, followed by radiochemical separation and purification. Continuous improvements in research reactors, neutron activation techniques, accelerator production methods, and automated radiochemical processing have led to enhanced production efficiency, purity control, and batch-to-batch consistency for ^199Au. Moreover, the growing demand for high-quality isotopes from nuclear medicine institutions and radiopharmaceutical companies is driving suppliers to refine their radionuclide production, quality control, and safety management systems. In the future, institutions possessing nuclear facility resources, radiochemical capabilities, and regional supply networks will maintain a competitive advantage in the Gold-199 market.
Report Scope
This report is a detailed and comprehensive analysis for global Gold-199 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gold-199 market size and forecasts, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Gold-199 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Gold-199 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Gold-199 market shares of main players, shipments in revenue ($ Million), sales quantity (Gram), and ASP (US$/g), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gold-199
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gold-199 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NIDC(DOE IP), Materion, Rosatom, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Gold-199 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Activity Concentration＜10mCi/µL
Activity Concentration≥10mCi/µL
Market segment by Product Form
Gold-199 Solution
Colloidal Gold-199
Gold-199 Nanoparticles
Gold-199 Standard Source
Market segment by Radiochemical Purity
Research-grade Gold-199
High-radiochemical-purity Gold-199
Clinical-grade Gold-199
Market segment by Production Route
Reactor-produced Gold-199
Accelerator-produced Gold-199
Laboratory-produced Gold-199
Market segment by Application
Nuclear Medicine
Environmental Testing
Major players covered
NIDC(DOE IP)
Materion
Rosatom
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Gold-199 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gold-199, with price, sales quantity, revenue, and global market share of Gold-199 from 2021 to 2026.
Chapter 3, the Gold-199 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gold-199 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Gold-199 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gold-199.
Chapter 14 and 15, to describe Gold-199 sales channel, distributors, customers, research findings and conclusion.